Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KCT0008120Phase 4Completed
Phase 4, open-label, single-arm trial of remimazolam, sponsored by Ajou University Hospital. Primary endpoints: EC50 for anesthesia induction and EC95 for anesthesia induction. Started Feb 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on KCT0008120.